Related Experiment Video
Updated: May 31, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Mechanism of Corylin Inhibiting the Development of Osteosarcoma: Regulating HMGB1/p38 MAPK Signaling
Rongyao Yan1, Hao Wang1, Zhenyu Cai1
1Department of Orthopedics, Quanzhou First Hospital Affiliated to Fujian Medical University, 362000 Quanzhou, Fujian, China.
Background:
High-mobility group box 1 (HMGB1) participates in the progression of osteosarcoma (OS) through the p38 mitogen-activated protein kinase (MAPK) signaling pathway. Corylin, one of the active components of Psoralea corylifolia L., has anti-oxidant, anti-inflammatory, and anti-tumor effects. This study investigates the association between corylin and HMGB1, and their impact and mechanism of action on OS.
Methods:
OS cells and osteoblasts were transfected with/without HMGB1 overexpression plasmid and siHMGB1. Cell viability was examined using the Cell Counting Kit-8 (CCK-8) assay after treatment with corylin (0, 2.5, 5, 10, 30 μM). The effects of corylin on cell malignant behaviors were examined by cell function assays. The mRNA expression level of high-mobility group box 1 (HMGB1) was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The protein levels of HMGB1, matrix metalloproteinase-2 (MMP-2), MMP-9, and alpha-smooth muscle actin (α-SMA) were measured by western blotting. The effects of corylin and HMGB1 on the expression of p38 MAPK signaling pathway-related proteins were also assessed.
Results:
Corylin decreased OS cell viability, proliferation, migration, and invasion but increased apoptosis in a concentration-dependent manner. Corylin concentration-dependently suppressed the levels of HMGB1, MMP-2, MMP-9, and α-SMA. Overexpression of HMGB1 was partially reversed, while knockdown of HMGB1 enhanced the above effects of corylin.
Conclusion:
Corylin inhibits OS cell migration and invasion through regulation of the HMGB1-mediated p38 MAPK signaling pathway.
Insights
Corylin, derived from Psoralea corylifolia L., inhibits osteosarcoma (OS) progression by suppressing High-mobility group box 1 (HMGB1) and the p38 MAPK pathway. This natural compound reduces tumor cell viability, migration, and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- High-mobility group box 1 (HMGB1) protein is implicated in osteosarcoma (OS) progression via the p38 MAPK signaling pathway.
- Corylin, a component of Psoralea corylifolia L., exhibits anti-tumor properties.
Purpose of the Study:
- To investigate the relationship between corylin and HMGB1 in OS.
- To elucidate the mechanism of action of corylin on OS cells, focusing on the HMGB1-mediated p38 MAPK pathway.
Main Methods:
- Osteosarcoma cells were treated with varying concentrations of corylin.
- HMGB1 expression was manipulated using overexpression plasmids and siRNA.
- Cell viability, proliferation, migration, invasion, and apoptosis were assessed.
- Protein and mRNA levels of HMGB1, MMP-2, MMP-9, α-SMA, and p38 MAPK pathway components were analyzed via CCK-8, cell function assays, RT-qPCR, and western blotting.
Main Results:
- Corylin reduced OS cell viability, proliferation, migration, and invasion while increasing apoptosis in a dose-dependent manner.
- Corylin suppressed HMGB1, MMP-2, MMP-9, and α-SMA levels.
- HMGB1 overexpression partially reversed corylin's effects, whereas HMGB1 knockdown enhanced them.
Conclusions:
- Corylin demonstrates anti-cancer effects in osteosarcoma.
- Corylin inhibits OS cell migration and invasion by regulating the HMGB1-mediated p38 MAPK signaling pathway.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway

